Castleark Management’s Array Biopharma Inc ARRY Stock Holding History

Castleark Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-162,251	Closed	-$7.52M	–	415
2019 Q2	$7.52M	Sell	162,251 -57,865	-26%	-$1.62M	0.29%	119
2019 Q1	$5.37M	Buy	+220,116	New	+$4.58M	0.2%	153
2018 Q3	–	Sell	-331,435	Closed	-$5.56M	–	430
2018 Q2	$5.56M	Buy	331,435 +99,430	+43%	+$1.58M	0.17%	182
2018 Q1	$3.79M	Buy	+232,005	New	+$3.72M	0.12%	215
2017 Q2	–	Sell	-349,781	Closed	-$3.13M	–	441
2017 Q1	$3.13M	Buy	+349,781	New	+$3.72M	0.1%	237

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Castleark Management's ARRY Position: Q3 2019 in Review

Castleark Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 162,251 shares — an estimated $7.52M sold.

Castleark Management first reported a position in ARRY in Q1 2017 and held it in 5 quarters. The position peaked at $7.52M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Castleark Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Castleark Management sold 162,251 Array Biopharma Inc shares in Q3 2019, an estimated $7.52M.
Castleark Management first reported a position in Array Biopharma Inc in Q1 2017 and held it in 5 quarters.
Castleark Management's Array Biopharma Inc position peaked at $7.52M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Castleark Management's 13F filing for Q3 2019, filed 15 Nov 2019.